FDA Reopens Comment Period on Draft Risk Assessment for Vibrio Parahaemolyticus in Raw Molluscan Shellfish

Summary

The FDA is extending the comment period on its draft risk assessment for Vibrio parahaemolyticus in raw molluscan shellfish until July 18, 2001, in response to a request from industry groups, and will not consider further extensions.